Cargando…

Scale up and pharmacokinetic study of a novel mutated chimeric tissue plasminogen activator (mt-PA) in rats

Because of high mortality caused by cardiovascular diseases, various fibrinolytic agents with diverse pharmacokinetic and pharmacodynamic properties have been developed. A novel mutated chimeric tissue plasminogen activator (mt-PA) was developed by the removal of first three domains of t-PA, inserti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raigani, Mozhgan, Rouini, Mohammad-Reza, Golabchifar, Ali-Akbar, Mirabzadeh, Esmat, Vaziri, Behrouz, Barkhordari, Farzaneh, Davami, Fatemeh, Mahboudi, Fereidoun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320447/ https://www.ncbi.nlm.nih.gov/pubmed/28223717 http://dx.doi.org/10.1038/srep43028

Ejemplares similares

Optimization of EnBase Fed-Batch Cultivation to Improve Soluble Fraction Ratio of α-Luffin Ribosome Inactivating Protein
por: Barkhordari, Farzaneh, et al.
Publicado: (2018)

Proteomics Profiling of Chimeric-Truncated Tissue Plasminogen activator Producing- Chinese Hamster Ovary Cells Cultivated in a Chemically Defined Medium Supplemented with Protein Hydrolysates
por: Azarian, Bahareh, et al.
Publicado: (2017)

Woodchuck Hepatitis Virus Post-Transcriptional Regulation Element (WPRE) Promotes Anti-CD19 BiTE Expression in Expi293 Cells
por: Moazzami, Reza, et al.
Publicado: (2021)

Effect of Peptone Feeding on Transient Gene Expression Process in CHO DG44
por: Davami, Fatemeh, et al.
Publicado: (2014)

Expression of a Novel Chimeric Truncated t-PA in CHO Cells Based on in Silico Experiments
por: Davami, Fatemeh, et al.
Publicado: (2010)

Effects of Peptone Supplementation in Different Culture Media on Growth, Metabolic Pathway and Productivity of CHO DG44 Cells; a New Insight into Amino Acid Profiles
por: Davami, Fatemeh, et al.
Publicado: (2015)

Designed Amino Acid Feed in Improvement of Production and Quality Targets of a Therapeutic Monoclonal Antibody
por: Torkashvand, Fatemeh, et al.
Publicado: (2015)

Evaluating the efficiency of CHEF and CMV promoter with IRES and Furin/2A linker sequences for monoclonal antibody expression in CHO cells
por: Ebadat, Saeedeh, et al.
Publicado: (2017)

Human Tissue Plasminogen Activator Expression in Escherichia coli using Cytoplasmic and Periplasmic Cumulative Power
por: Majidzadeh-A, Keivan, et al.
Publicado: (2010)

Evaluating the expression profile and stability of different UCOE containing vector combinations in mAb-producing CHO cells
por: Nematpour, Fatemeh, et al.
Publicado: (2017)

Monoclonal antibodies expression improvement in CHO cells by PiggyBac transposition regarding vectors ratios and design
por: Ahmadi, Samira, et al.
Publicado: (2017)

Trastuzumab Charge Variants: a Study on Physicochemical and Pharmacokinetic Properties
por: Torkashvand, Fatemeh, et al.
Publicado: (2023)

Production of an Antibody Fragment (scFv) Targeting PcrV Protein of Pseudomonas aeruginosa in Fed-Batch Cultivation Mode
por: Karam, Saba, et al.
Publicado: (2021)

Physicochemical Characterization of Altebrel™, a Proposed Etanercept Biosimilar
por: Fazel, Ramin, et al.
Publicado: (2019)

Effect of Cysteamine on Cell Growth and IgG(4) Production in Recombinant Sp2.0 Cells
por: Jahandar, Hoda, et al.
Publicado: (2015)

MALDI-MS: a Rapid and Reliable Method for Drug-to-Antibody Ratio Determination of Antibody-Drug Conjugates
por: Abedi, Mehri, et al.
Publicado: (2019)

The Epigenetic Regulation of Blinatumomab Gene Expression: Tumor Cell-dependent T cell Response against Lymphoma Cells and Cytotoxic Activity
por: Naddafi, Fatemeh, et al.
Publicado: (2019)

Construction of a Mammalian IRES-based Expression Vector to Amplify a Bispecific Antibody; Blinatumomab
por: Naddafi, Fatemeh, et al.
Publicado: (2019)

Expression of granulocyte colony stimulating factor (GCSF) in Hansenula polymorpha
por: Talebkhan, Yeganeh, et al.
Publicado: (2016)

Quantitative Proteomic Analysis of Cellular Responses to a Designed Amino Acid Feed in a Monoclonal Antibody Producing Chinese Hamster Ovary Cell Line
por: Torkashvand, Fatemeh, et al.
Publicado: (2018)

Improvement of Certolizumab Fab′ properties by PASylation technology
por: Mazaheri, Somayeh, et al.
Publicado: (2020)

Periplasmic Expression of a Novel Human Bone Morphogenetic Protein-7 Mutant in Escherichia coli
por: Nematollahi, Leila, et al.
Publicado: (2012)

Efficient site-specific integration in CHO-K1 cells using CRISPR/Cas9-modified donors
por: Kheirandish, Mohammad Hassan, et al.
Publicado: (2023)

A systems medicine approach for finding target proteins affecting treatment outcomes in patients with non-Hodgkin lymphoma
por: Ajorloo, Faezeh, et al.
Publicado: (2017)

The Role of Different Supplements in Expression Level of Monoclonal Antibody against Human CD20
por: Mahboudi, Fereidoun, et al.
Publicado: (2013)

uPA-mediated plasminogen activation is enhanced by polyphosphate
por: Whyte, Claire S., et al.
Publicado: (2020)

Single-Chain Variable Fragment-Based Bispecific Antibodies: Hitting Two Targets with One Sophisticated Arrow
por: Ahamadi-Fesharaki, Raoufeh, et al.
Publicado: (2019)

Impacts of tissue-type plasminogen activator (tPA) on neuronal survival
por: Chevilley, Arnaud, et al.
Publicado: (2015)

In silico and in vivo analyses of the mutated human tissue plasminogen activator (mtPA) and the antithetical effects of P19 silencing suppressor on its expression in two Nicotiana species
por: Amiri, Mahshid, et al.
Publicado: (2018)

Post-synaptic Release of the Neuronal Tissue-Type Plasminogen Activator (tPA)
por: Lenoir, Sophie, et al.
Publicado: (2019)

The autoactivation of human single-chain urokinase-type plasminogen activator (uPA)
por: Torres-Paris, Constanza, et al.
Publicado: (2023)

Evaluation of antibody responses to outer membrane vesicles (OMVs) and killed whole cell of Vibrio cholerae O1 El Tor in immunized mice
por: Sedaghat, Manijeh, et al.
Publicado: (2019)

Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas.
por: Bouchet, C., et al.
Publicado: (1994)

Efficacy of probiotics for managing infantile colic due to their anti-inflammatory properties: a meta-analysis and systematic review
por: Shirazinia, Reza, et al.
Publicado: (2021)

Characterization of a novel mCH3 conjugated anti-PcrV scFv molecule
por: Komijani, Samira, et al.
Publicado: (2021)

Microglia and the urokinase plasminogen activator receptor/uPA system in innate brain inflammation
por: Cunningham, Orla, et al.
Publicado: (2009)

The Influence of Tissue Plasminogen Activator I/D Polymorphism on the tPA Response to Exercise
por: COUGHLIN, ADAM M., et al.
Publicado: (2018)

Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast cancer - correlation with traditional prognostic factors
por: Lampelj, Maja, et al.
Publicado: (2015)

Alu-repeat polymorphism in the tissue plasminogen activator (t-PA) gene, seminal t-PA concentration, and male fertility impairment: A case-control study
por: Tahtamouni, Lubna Hamid, et al.
Publicado: (2020)

The effect of teaching puberty health concepts on the basis of a health belief model for improving perceived body image of female adolescents: a quasi-experimental study
por: Barkhordari-Sharifabad, Maasoumeh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0aulsnttarmb2ubdkt043qpthl